The phrase "abnormal pet" is correct and usable in written English.
It can be used to describe a pet that exhibits unusual or atypical behavior or characteristics compared to what is considered normal for its species.
Example: "The veterinarian noted that my cat had an abnormal pet behavior, such as excessive vocalization and hiding for long periods."
Alternatives: "unusual pet" or "atypical pet".
Spaepen et al.[ 80 ] evaluated 70 patients with aggressive NHL after 3 4 cycles of therapy and demonstrated that none of 33 patients with abnormal PET imaging achieved a durable complete response whereas 31/37 with a normal PET scan remained in complete response (median follow-up 1107 days).
Spaepen et al. evaluated 70 patients with aggressive NHL after 3 4 cycles of therapy and demonstrated that none of 33 patients with abnormal PET imaging achieved a durable complete response whereas 31/37 with a normal PET scan remained in complete response (median follow-up 1107 days) [ 48].
Fifteen patients had abnormal PET findings, i.e., focal hypometabolism in 9 patients and displaced metabolic activity of normal gray matter in 6.
This group comprised the 44 children with abnormal PET at visual analysis and the three patients excluded from the previous group.
Group I (pseudo-control group) comprised the 24 children with negative MRI and negative (normal) PET; group II (patient group) comprised the remaining 47 children with positive (abnormal) PET (20 had positive MRI, 27 had negative MRI).
Identification of abnormal PET signal in IPF, undetectable on HRCT, could give an insight into the pathogenesis of the disease and may permit earlier detection of changes in disease activity.
Our computational platform can also provide automated tumor volume measurement using the same approach as the demonstrated measurement of abnormal PET-CT findings in infection to provide serial volumetric data and longitudinal changes in SUV intensity.
Of 25 patients with a positive PET-CT, the probability of progression was 87% at 2 years in those with evidence of underlying osteolysis (n=16) and 61% in patients with abnormal PET-CT uptake but no evidence of osteolysis (n=9).
In this study, we show that patients with suspected SMM who have an abnormal PET-CT (clinical radiologist interpretation of increased bone uptake and/or evidence of lytic bone destruction) who are observed without therapy are at high risk (75%) of progression to MM within 2 years.
Among patients with a positive PET-CT, the probability of progression was 87% at 2 years in the subset of patients with underlying osteolysis (n=16) and 61% in patients with abnormal PET-CT uptake but no evidence of osteolysis (n=9), P=0.31.
Abnormal amyloid PET was defined as SUVR >1.40, which was recently validated by autopsy correlation with Thal amyloid phase (Murray et al., 2015).
